MEDIRAD to feature at ECR 2019

Cardiovascular effects after radiotherapy for breast cancer (WP4) will be presented in a dedicated MEDIRAD session at the European Congress of Radiology (ECR) 2019 in Vienna, Austria, on 27 February - 3 March 2019. This session will take place on Wednesday, 27 February at 08:30 - 10:00 in Room N. 

Programme of "EU 1 - Cardiovascular effects after radiotherapy for breast cancer: the European MEDIRAD Project":

  1. Chairpersons' introduction by A. Crijns (UMCG, NL) and G. Frija (UPDescartes, FR)
  2. Overview of dose-effect relationships and their use in strategies for prevention of cardiovascular effects after radiotherapy for breast cancer by A. Crijns (UMCG, NL)
  3. Optimisation of multivariable prediction models for major cardiac events after radiotherapy for breast cancer by D.S. Spoor (UMCG, NL)
  4. The MEDIRAD Early-Heart study by S. Jacob (IRSN, FR)
  5. Imaging biomarkers of cardiovascular effects of incidental cardiac radiation by E. Mousseaux (UPDescartes, FR)
  6. Discussion


Posted on 18/01/2019